Delivery Order SPE2DB22D3501-SPE2DB25FVK42
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,662.57 on September 16, 2025, for the supply of Tagrisso 80 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 7, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified vendors. This...
- The Defense Logistics Agency awarded a $31,987.71 delivery order to AmerisourceBergen Drug Corp for 30-tablet units of Tagrisso 80 mg tablets under a firm fixed price contract. This delivery order, issued on September 25, 2025, with an ultimate completion date of October 17, 2025, represents a non-competitive set-aside award to the pharmaceutical distributor. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $11,236.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Tagrisso 80 mg tablets (30-count). The contract will be performed at the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of December 1, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Tagrisso 40 mg tablets (30-count units) with a ceiling value of $10,641.07. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is set to be completed by October 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count packages). This competitive award, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance of this contract will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Tagrisso is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Tagrisso 80 mg tablets in quantities of 30, with a ceiling value of $11,236.71. This firm fixed-price delivery order is expected to be completed by January 22, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is unclassified as a set-aside contract and represents a competitive award to AmerisourceBergen, one of the...
- The Defense Logistics Agency awarded a delivery order valued at $22,473.42 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count) on November 20, 2025, with an ultimate completion date of December 12, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11.2K delivery order to AmerisourceBergen Drug Corp for Tagrisso 80 mg tablets (30-count units) on December 2, 2025, with completion scheduled for December 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, supplies a...
- The Defense Logistics Agency awarded a $82.4K delivery order to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) under a firm fixed-price contract. The award was made on October 29, 2025, with an ultimate completion date of November 20, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Tagrisso 80 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, awarded on September 23, 2025, carries a ceiling value of $10,662.57 and is scheduled for completion by October 15, 2025. The award was made on a competitive basis without any set-aside designation, and the place of...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FVK42Delivery Order
The Defense Logistics Agency awarded a $21,325.14 delivery order to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) under a firm fixed-price contract. The order, issued on April 23, 2025, with an ultimate completion date of May 14, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and fulfills this delivery order as a child contract under a larger indefinite delivery vehicle. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables comprehensive pharmaceutical support to military healthcare systems worldwide, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. The DLA Troop Support is concurrently planning Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple anticipated awards across separate regions, positioning AmerisourceBergen as a key supplier for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.3k | 4/23/25 |